Product Name: Human CSF2 / GM-CSF Antibody (Lenzilumab, Research Use)
Catalog Number: NBR-0616
Target Name: CSF2 / GM-CSF
Trade Name: Lenzilumab
Antibody Drug Description: Lenzilumab (KB003) is a novel, IgG1 κ monoclonal antibody targeted to human GM-CSF and administered as an intravenous (IV) infusion on days 1 and 15 of a 28-day cycle. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CSF2
Synonyms: GMCSF; Sargramostim; GM-CSF
Target Description: CSF2 (Colony Stimulating Factor 2) is a Protein Coding gene. Diseases associated with CSF2 include Pulmonary Alveolar Proteinosis and Mucositis. Among its related pathways are MIF Mediated Glucocorticoid Regulation and Gene expression (Transcription). Gene Ontology (GO) annotations related to this gene include cytokine activity and granulocyte macrophage colony-stimulating factor receptor binding.
Ensembl: ENSG00000164400
Uniprot: P04141